Related Experiment Videos
[Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties]
H B Ettema1, M R Hoppener, H R Büller
1Academisch Medisch Centrum/Universiteit van Amsterdam, Amsterdam. c.c.p.m.verheyen@isala.nl
Nederlands Tijdschrift Voor Geneeskunde
|October 10, 2003
Summary
Prophylactic treatment is recommended for patients undergoing major orthopedic surgery to prevent deep venous thrombosis (DVT). Low molecular-weight heparin or coumarin derivatives are more effective than unfractionated heparin or aspirin for DVT prevention.
Area of Science:
- Orthopedic Surgery
- Vascular Medicine
- Pharmacology
Background:
- Deep venous thrombosis (DVT) is a risk after major orthopedic surgery, necessitating prophylactic measures.
- Identifying high-risk patients is challenging, making routine prophylaxis advisable.
- Current prophylaxis strategies aim to reduce DVT incidence and improve patient outcomes.
Discussion:
- Low molecular-weight heparin (LMWH) and coumarin derivatives demonstrate superior efficacy in DVT prevention compared to unfractionated heparin (UFH).
- Acetylsalicylic acid (aspirin) lacks proven benefit in elective hip/knee surgery and its role in hip fracture treatment is uncertain.
- Postoperative initiation of prophylaxis is as safe and effective as preoperative initiation.
- Extended prophylaxis duration (4-6 weeks) after hip/knee arthroplasty significantly lowers thrombosis rates.
Key Insights:
- LMWH and coumarins are preferred over UFH and aspirin for DVT prophylaxis in major orthopedic surgery.
- Prophylaxis can be initiated postoperatively with comparable safety and efficacy.
- Extended prophylaxis duration is associated with reduced thrombosis incidence.
- Mechanical prophylaxis methods like intermittent pneumatic compression show limited practical application.
Outlook:
- Further research is needed to determine the optimal duration for medicinal DVT prophylaxis.
- Investigating the efficacy of prophylaxis in day surgery settings is warranted due to insufficient data.
- Exploring novel prophylactic strategies and refining existing ones for orthopedic patients remains crucial.